Skip to main content

Table 3 Molecular subtypes in association with breast cancer survival, the Shanghai Breast Cancer Survival Study.

From: Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study

  Overall survival Disease-free survival
  Cases Events 5-yr survival rate HR1* (95% CI) HR2** (95% CI) Cases Events 5-yr survival rate HR1* (95% CI) HR2** (95% CI)
Luminal A 1258 97 0.9286 1.00 1.00 1234 121 0.8863 1.00 1.00
Luminal B 419 48 0.8862 1.57 (1.10 - 2.22) 1.17 (0.82 - 1.68) 410 57 0.8506 1.42 (1.03 - 1.95) 1.04 (0.75 - 1.43)
HER2 322 60 0.8322 2.12 (1.50 - 3.00) 1.47 (1.03 - 2.10) 312 70 0.7907 1.94 (1.41 - 2.67) 1.32 (0.95 - 1.83)
Triple-negative 298 62 0.8069 2.50 (1.78 - 3.51) 1.87 (1.31 - 2.66) 292 68 0.7600 2.12 (1.55 - 2.91) 1.52 (1.09 - 2.11)
HER2 borderline 204 23 0.8768 1.46 (0.93 - 2.32) 1.42 (0.90 - 2.26) 202 25 0.8788 1.19 (0.77 - 1.84) 1.15 (0.75 - 1.79)
  1. *HR1: Adjusted for age, education, income, BMI, radiotherapy, chemotherapy, immunotherapy, and tamoxifen use.
  2. **HR2: Further adjusted for TNM, histologic grade, and tumor size